Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Desert Gold Report Results from 3,900 Meter Phase 2 Exploration Drill Program (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Healthcare Biotechnology
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

Research and Markets: Cloud Market In Healthcare technologies, EHR Market, Digital pathology market, Clinical, EMR, SaaS, Bioinformatics, Digital pathology, Hybrid Market 2014 - 2020

Business Wire December 12, 2014

FuelCell Energy Solutions Announces Final Acceptance of Largest Fuel Cell Power Plant Made and Operating in Germany

Thomson Reuters ONE December 12, 2014

Galapagos selects second component of its investigational cystic fibrosis combination treatment

GlobeNewswire December 12, 2014

Galapagos selects second component of its investigational cystic fibrosis combination treatment

Thomson Reuters ONE December 12, 2014

Ipsen Announces That the International Breast Cancer Study Group (IBCSG) Presented Phase 3 Results Evaluating the Use of Ovarian Suppression to Adjuvant Treatment with Tamoxifen

Business Wire December 12, 2014

Nektar Presents Data on Target-Specific Biomarkers from Circulating Tumor Cell Sub-Study of Phase 3 BEACON Study of Etirinotecan Pegol (NKTR-102) in Patients with Advanced Breast Cancer

PR Newswire December 11, 2014

Jazz Pharmaceuticals Initiates Rolling NDA Submission For Defibrotide For The Treatment Of Severe Hepatic Veno-Occlusive Disease

PR Newswire December 11, 2014

Amgen And AstraZeneca To Present Results From Phase 3 AMAGINE-1(TM) Study Evaluating Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis

PR Newswire December 11, 2014

Alnylam Initiates ENDEAVOUR Phase 3 Clinical Trial with Revusiran (ALN-TTRsc), an Investigational RNAi Therapeutic Targeting Transthyretin (TTR) for the Treatment of TTR Cardiac Amyloidosis

Business Wire December 11, 2014

San Antonio Breast Cancer Symposium 2014: The New Way to Treat Triple-negative Breast Cancer is "Made in Italy"

Canada NewsWire December 11, 2014

Virginia Bio Welcomes Two New Members to its Board of Directors

Business Wire December 11, 2014

International Cancer Genome Consortium enters partnership with Annai Systems Inc. to bring cancer genome data to researchers worldwide

Canada NewsWire December 11, 2014

The Association for Molecular Pathology Closes Out 2014 Annual Meeting With Record-Level Attendance

Business Wire December 11, 2014

An important study for Parkinson's disease - IRCM researchers uncover a mechanism regulating dopamine levels in the brain

Canada NewsWire December 11, 2014

Research and Markets: PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2023: Market to More than Treble in Value

Business Wire December 11, 2014

One of the Most Difficult Challenges in Weight Loss is Keeping the Weight Off Over the Long Term

PR Newswire December 11, 2014

Parent Project Muscular Dystrophy To Collaborate With Catabasis Pharmaceuticals, Inc. On CAT-1004 Development

PR Newswire December 11, 2014

Dr. Haim Danenberg joins CBSET as Chief Scientific Adviser

Business Wire December 11, 2014

Lakewood-Amedex Submits Investigational New Drug Application for Bisphosphocin(TM) Nu-3 for the Treatment of Diabetic Foot Infections

PR Newswire December 11, 2014

Research and Markets: 3D Applications in Healthcare Market - 2014 - 2020

Business Wire December 11, 2014